- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin monotherapy with premixed insulin NPH 30/70
Total 115 results
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCanada
-
Novo Nordisk A/SCompletedDiabetes | Type 2 Diabetes MellitusTaiwan, Turkey, India, Algeria, Hong Kong, China, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSlovakia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMacedonia, The Former Yugoslav Republic of
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Acute Myocardial InfarctionCanada, Croatia, Czech Republic, Germany, Hungary, India, Israel, Lebanon, Poland, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Turkey, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Egypt, Morocco, Indonesia, Tunisia, Vietnam
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIran, Islamic Republic of
-
GeropharmCompletedClamp StudyRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesRussian Federation, Ukraine
-
Tehran University of Medical SciencesCompletedDiabetes Type 2Iran, Islamic Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan, Malaysia, Taiwan, Korea, Republic of, Hong Kong
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Denmark, Sweden, Malaysia, Poland, Turkey, Finland, Australia, Thailand, Taiwan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Austria
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Hospital Universitario Central de AsturiasSanofiTerminated
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
GeropharmCompletedBioequivalenceRussian Federation
-
Medical University of GrazCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesJapan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesAustria, Hungary, Slovenia, Germany, Czech Republic, Poland, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Serbia, Bulgaria, Australia, Korea, Republic of, Thailand, Turkey, United Arab Emirates, Hungary
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany
-
Julphar Gulf Pharmaceutical IndustriesProfil Institut für Stoffwechselforschung GmbHCompleted
-
Novo Nordisk A/SCompletedObservational Study on Blood Glucose Control in Patients With Diabetes Using Modern Insulin (COMMIT)Diabetes Mellitus, Type 2 | DiabetesSlovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCzech Republic
-
Yaounde Central HospitalCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesMorocco, Tunisia, Algeria, South Africa, Egypt
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1United Kingdom, France, Netherlands, Belgium, Ireland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Saudi Arabia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Aristotle University Of ThessalonikiUniversity Hospital TuebingenCompletedDiabetes Mellitus, Type 2
-
WockhardtCompletedDiabetes MellitusUnited States
-
Biocon LimitedProfil Institut für Stoffwechselforschung GmbHCompletedHealthy VolunteerGermany
-
Novo Nordisk A/SCompleted
-
Xijing HospitalXi'an Central Hospital; First Affiliated Hospital Xi'an Jiaotong University; Shaanxi... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
GeropharmUnknownEfficacy and Safety of GP40081 Сompared to NovoMix® 30 FlexPen® in Type 2 Diabetes Mellitus PatientsDiabetes Mellitus, Type 2 | Diabetes MellitusRussian Federation
-
SanofiCompletedType 2 Diabetes MellitusChina
-
Cairo UniversityCompletedDiabetes Mellitus (DM)Egypt
-
University of AarhusNovo Nordisk A/SCompleted
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesGreece
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of, India, Malaysia, Turkey, Argentina, Greece, Australia, Portugal, Thailand, Brazil
-
Vanderbilt UniversitySanofiCompleted